These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2866336)

  • 1. Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudication.
    Bounameaux H; Holditch T; Hellemans H; Berent A; Verhaeghe R
    Lancet; 1985 Dec; 2(8467):1268-71. PubMed ID: 2866336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants. Changes in claudication distance and ankle systolic pressure. PACK Claudication Substudy.
    Circulation; 1989 Dec; 80(6):1544-8. PubMed ID: 2688971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of ketanserin on the leg perfusion assessed by Doppler pressure measurements and 201Tl scintigraphy in patients with intermittent claudication.
    Bounameaux H; Devos P; Verhaeghe R
    J Cardiovasc Pharmacol; 1985; 7(6):1083-6. PubMed ID: 2418292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PACK trial: morbidity and mortality effects of ketanserin. Prevention of Atherosclerotic Complications.
    Verstraete M
    Vasc Med; 1996; 1(2):135-40. PubMed ID: 9546928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin in intermittent claudication. A double-blind placebo-controlled study.
    Clement DL; Duprez D; Van Wassenhove A; Brusselmans F
    Int Angiol; 1989; 8(2):92-6. PubMed ID: 2681451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications.
    Thulesius O; Lundvall J; Kroese A; Stranden E; Hallböök T; Brunes L; Gjöres JE; Akesson H; Einarsson E; Ohlin P
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):728-33. PubMed ID: 2442541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
    Cameron HA; Waller PC; Ramsay LE
    Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized placebo-controlled, double-blind trial of ketanserin in treatment of intermittent claudication.
    Walden R; Bass A; Rabi I; Adar R
    J Cardiovasc Surg (Torino); 1991; 32(6):737-40. PubMed ID: 1752890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ketanserin on macrocirculatory and microcirculatory blood flow in patients with intermittent claudication. A prospective randomized study.
    Beckers RC; Jörning PJ; Slaaf DW; Reneman RS; Jacobs MJ
    Eur J Clin Pharmacol; 1989; 37(3):295-6. PubMed ID: 2693113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm.
    De Caterina R; Carpeggiani C; L'Abbate A
    Circulation; 1984 May; 69(5):889-94. PubMed ID: 6705164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ketanserin in the treatment of patients with intermittent claudication: results from 13 placebo-controlled parallel group studies.
    Clement DL; Duprez D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S89-95. PubMed ID: 2446082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial. The PACK Trial Group.
    Thromb Res; 1989 Jul; 55(1):13-23. PubMed ID: 2528841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
    Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V; Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Dandona P
    Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.
    De Cree J; Geukens H; Gutwirth P; De Clerck F; Vercammen E; Verhaegen H
    Int Angiol; 1993 Mar; 12(1):59-68. PubMed ID: 8376914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of claudication: vasodilators, hemorrheologic agents, and antiserotonin drugs.
    Taylor LM; Porter JM
    J Vasc Surg; 1986 Feb; 3(2):374-81. PubMed ID: 2935646
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    Clin Exp Hypertens A; 1984; 6(6):1107-17. PubMed ID: 6146414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of blood pressure ratio by Doppler velocimetry and by plethysmography during treatment with ketanserin, a 5-HT2 receptor antagonist: a measure of improved collateral and microcirculatory flow.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S92-4. PubMed ID: 2412069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.